Dale Shepard

Hematology | Oncology

9500 Euclid Ave
Cleveland, OH 44195

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Response to: "Comment on: risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors".

Response to: "Comment on: risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors".

Journal: Eye (London, England)

Published: May 08, 2026

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.

Journal: The New England journal of medicine

Published: February 25, 2026

Expert Perspectives on TGCT and the Outcomes of the Phase 3 MANEUVER Study of Pimicotinib Presented at ASCO and ESMO 2025: A Podcast Discussion.

Expert Perspectives on TGCT and the Outcomes of the Phase 3 MANEUVER Study of Pimicotinib Presented at ASCO and ESMO 2025: A Podcast Discussion.

Journal: Advances in therapy

Published: February 05, 2026

Neighborhood socioeconomic disadvantage is associated with worse survival in localized extremity soft tissue sarcoma.

Neighborhood socioeconomic disadvantage is associated with worse survival in localized extremity soft tissue sarcoma.

Journal: BMC cancer

Published: February 02, 2026

Consensus recommendations in the management of jaw (gnathic) osteosarcoma.

Consensus recommendations in the management of jaw (gnathic) osteosarcoma.

Journal: Cancer

Published: September 24, 2025

Consensus recommendations in the management of jaw (gnathic) osteosarcoma.

Consensus recommendations in the management of jaw (gnathic) osteosarcoma.

Journal: Cancer

Published: September 24, 2025

Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors.

Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors.

Journal: Eye (London, England)

Published: August 21, 2025

Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma.

Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma.

Journal: Current treatment options in oncology

Published: July 24, 2025

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma.

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma.

Journal: ESMO open

Published: August 01, 2024

Management of Desmoid Disease in Familial Adenomatous Polyposis.

Management of Desmoid Disease in Familial Adenomatous Polyposis.

Journal: Clinics in colon and rectal surgery

Published: April 12, 2024

Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer.

Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer.

Journal: Oncology (Williston Park, N.Y.)

Published: December 22, 2023

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 12, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026